Brief: Cellavision Q1 EBITDA Rises To SEK 46.2 Million

CellaVision AB

28/04/2021 07:32

April 28 (Reuters) - CellaVision AB  CEVI.ST :
    * CELLAVISION AB: STRONG PROFITABILITY AND POSITIVE
DEVELOPMENT IN
EUROPE
    * Q1 NET SALES SEK 134.0 MILLION VERSUS SEK 134.4 MILLION
YEAR AGO
    * COVID-19 PANDEMIC CONTINUED TO AFFECT CELLAVISION BUSINESS
IN Q1
OF YEAR, BUT IMPACT VARIED GREATLY BETWEEN OUR DIFFERENT REGIONS
    * Q1 EBITDA SEK 46.2 MILLION VERSUS SEK 41.2 MILLION YEAR
AGO
    * OUR SALES IN AMERICAS CONTINUED TO BE NEGATIVELY IMPACTED
BY
COVID-19 PANDEMIC IN Q1 OF 2021

Source text for Eikon:  ID:nMFN5vgZZP 
Further company coverage:  CEVI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))